Parkinson’s disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM

Kun Zhao(Chinese Academy of Sciences), Yeh‐Jun Lim(Tsinghua University), Zhenying Liu(Chinese Academy of Sciences), Houfang Long(Chinese Academy of Sciences), Yunpeng Sun(Chinese Academy of Sciences), Jin‐Jian Hu(Tsinghua University), Chunyu Zhao(Chinese Academy of Sciences), Youqi Tao(Shanghai Jiao Tong University), Xing Zhang(Sir Run Run Shaw Hospital), Dan Li(Shanghai Jiao Tong University), Yanmei Li(Tsinghua University), Cong Liu(Chinese Academy of Sciences)
Proceedings of the National Academy of Sciences
July 31, 2020
Cited by 200Open Access
Full Text

Abstract

Posttranslational modifications (PTMs) of α-synuclein (α-syn), e.g., phosphorylation, play an important role in modulating α-syn pathology in Parkinson's disease (PD) and α-synucleinopathies. Accumulation of phosphorylated α-syn fibrils in Lewy bodies and Lewy neurites is the histological hallmark of these diseases. However, it is unclear how phosphorylation relates to α-syn pathology. Here, by combining chemical synthesis and bacterial expression, we obtained homogeneous α-syn fibrils with site-specific phosphorylation at Y39, which exhibits enhanced neuronal pathology in rat primary cortical neurons. We determined the cryo-electron microscopy (cryo-EM) structure of the pY39 α-syn fibril, which reveals a fold of α-syn with pY39 in the center of the fibril core forming an electrostatic interaction network with eight charged residues in the N-terminal region of α-syn. This structure composed of residues 1 to 100 represents the largest α-syn fibril core determined so far. This work provides structural understanding on the pathology of the pY39 α-syn fibril and highlights the importance of PTMs in defining the polymorphism and pathology of amyloid fibrils in neurodegenerative diseases.


Related Papers

No related papers found

Powered by citation graph analysis